American Funds®

GROWTH FUNDS

®

302 Total Holdings:
As of 3/31/15 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 302
Asset Type
Novo Nordisk A/S, Class B Equity 56,236,585 $3,009,026,354.00 5.09%
Amazon.com, Inc. Equity 3,880,000 $1,443,748,000.00 2.44%
Regeneron Pharmaceuticals, Inc. Equity 2,265,150 $1,022,669,922.00 1.73%
Naspers Ltd., Class N Equity 6,045,060 $928,152,716.00 1.57%
Microsoft Corp. Equity 21,610,000 $878,554,550.00 1.49%
United Continental Holdings, Inc. Equity 12,490,000 $839,952,500.00 1.42%
AIA Group Ltd. Equity 127,676,400 $800,212,425.00 1.35%
Home Depot, Inc. Equity 6,668,100 $757,562,841.00 1.28%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 162,320,994 $753,059,079.00 1.27%
Priceline Group Inc. Equity 635,900 $740,282,985.00 1.25%
CME Group Inc., Class A Equity 7,429,332 $703,632,034.00 1.19%
Bayer AG Equity 4,685,000 $703,945,681.00 1.19%
Novartis AG Equity 6,815,000 $673,929,605.00 1.14%
Delta Air Lines, Inc. Equity 15,000,000 $674,400,000.00 1.14%
Avago Technologies Ltd. Equity 5,091,800 $646,556,764.00 1.09%
All Holdings: 1 - 15 of 302

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

  1. Excludes certain securities in initial period of acquisition.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.